Stock Market Reviews

Read and share opinions on XENE (Xenon Pharmaceuticals Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Xenon to Present at Upcoming Investor Conferences
  Nov 6, 2025
• Xenon Pharmaceuticals (XENE): Losses Widen 37% Annually, Challenging Bullish Revenue Growth Expectations
  Nov 5, 2025
• Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus
  Nov 4, 2025
• Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ...
  Nov 4, 2025
• Xenon Pharmaceuticals: Q3 Earnings Snapshot
  Nov 3, 2025
• Xenon to Report Q3 2025 Financial Results on November 3, 2025
  Oct 27, 2025
• Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
  Oct 16, 2025
• Xenon Pharmaceuticals (XENE): Exploring Valuation After Recent Share Price Momentum
  Oct 12, 2025
• Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  Oct 7, 2025
• Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
  Sep 25, 2025
• Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?
  Sep 10, 2025
• An Intrinsic Calculation For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Suggests It's 44% Undervalued
  Aug 21, 2025
• Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
  Aug 12, 2025
• Xenon Pharmaceuticals Inc (XENE) Q2 2025 Earnings Call Highlights: Strategic Advances and ...
  Aug 12, 2025
• Xenon Pharmaceuticals: Q2 Earnings Snapshot
  Aug 11, 2025